Bottom line
Is CIQRX a good fund? The bottom line
CIQRX is a share class of Segall Bryant & Hamill International Equity Fund, an actively managed international stock mutual fund from Segall Bryant & Hamill.
Its expense ratio is 0.99% — about $99 a year on every $10,000 invested, more expensive than 59% of international stock funds we track.
It returned +43.9% over one year (as of Dec 31, 2025, per its prospectus).
With $14.5 million in net assets and 344 holdings, its largest position is Asml Holding Nv (2.5%) and the top 10 make up 17.2% of the portfolio.
What stands out
- Broadly diversified (344 holdings)
What to watch
- Small fund ($14.5 million) — small funds are likelier to close
- High turnover (107% a year) can mean more taxable distributions
Updated Nov 19, 2026
What CIQRX invests in
The Segall Bryant & Hamill International Equity Fund (the SBH International Equity Fund or Fund) seeks to achieve long-term capital appreciation.
? Under normal circumstances, the Fund will invest at least 80% of its net assets (including amounts borrowed for investment purposes) in equity securities, primarily common stock, of companies located outside of the United States, ? The Funds Adviser considers a company to be international (that is outside of the United States) if: (i) it is organized under the laws of a foreign country or maintains its principal offices or headquarters in a foreign country; (ii) its securities are principally traded in a foreign country; or (iii) it derives at least 50% of its revenues or profits from goods produced or sold, investments made, or services performed in a foreign country, or has at least 50% of its assets in a foreign country. The Fund will allocate its assets among various regions and countries, with a minimum of ten countries. ? The Fund may purchase equity securities on exchanges…
From the fund's prospectus (filed Apr 29, 2026).
CIQRX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CIQRX | +43.9% | — | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What CIQRX costs
On a $10,000 investment, CIQRX's 0.99% expense ratio costs about $99 a year. The prospectus estimates $4,657 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
CIQRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Asml Holding Nv | 2.46% |
| 2 | Roche Holding Ag | 2.33% |
| 3 | Kioxia Holdings Corp | 2.01% |
| 4 | Novartis Ag | 1.65% |
| 5 | Banco Bilbao Vizcaya Argentaria Sa | 1.56% |
| 6 | Bnp Paribas Sa | 1.54% |
| 7 | Gsk Plc | 1.52% |
| 8 | Unicredit Spa | 1.49% |
| 9 | Natwest Group Plc | 1.34% |
| 10 | Infineon Technologies Ag | 1.29% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 17.2% of the fund. See all top 25 holdings and asset mix →